Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa.
Michael S
MS
Gelfand
Kerry O
KO
Cleveland
Shirin A
SA
Mazumder
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015780:Carbapenems / Q000494:pharmacology / Q000627:therapeutic use*; D000077726:Doripenem; D024881:Drug Resistance, Bacterial; D004660:Encephalitis / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D015378:Imipenem / Q000494:pharmacology; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification*; D014031:Tobramycin / Q000494:pharmacology / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D015378:Imipenem; D000077726:Doripenem; D014031:Tobramycin